Vinorelbine Tartrate and Paclitaxel in Treating Older Patients With Advanced Non-Small Cell Lung Cancer



Status:Completed
Conditions:Lung Cancer, Cancer, Cancer, Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:70 - Any
Updated:3/17/2019
Start Date:December 2007
End Date:August 2014

Use our guide to learn which trials are right for you!

Phase II Study of Weekly Vinorelbine and Paclitaxel in Elderly Patients With Advanced Non-Small Cell Lung Cancer

This phase II trial studies the side effects and how well vinorelbine tartrate and paclitaxel
works in treating older patients with non-small cell lung cancer that has spread to other
placed in the body. Drugs used in chemotherapy, such as vinorelbine tartrate and paclitaxel,
work in different ways to stop the growth of tumor cells, either by killing the cells, by
stopping them from dividing, or by stopping them from spreading. Giving combination
chemotherapy may kill more tumor cells.

PRIMARY OBJECTIVES: I. To assess the safety and efficacy of a combination of vinorelbine and
paclitaxel administered weekly to elderly patients with advanced non-small cell lung cancer.
II. To assess the response rate of a combination of vinorelbine and paclitaxel administered
weekly to elderly patients with advanced non-small cell lung cancer. III. To assess the
quality of life of elderly patients with advanced non-small cell lung cancer during
administration of weekly paclitaxel and vinorelbine. OUTLINE: Patients receive vinorelbine
tartrate intravenously (IV) over 6-10 minutes and paclitaxel IV over 1 hour once weekly for 6
weeks. Treatment repeats every 8 weeks for up to 2 courses in the absence of disease
progression or unacceptable toxicity. After completion of study treatment, patients are
followed up every 3 months for 2 years and then every 6 months for 5 years.

Inclusion Criteria:

- Pathologically proven non-small cell lung cancer with evidence of distant
metastases/malignant pleural effusion

- Measurable disease on imaging studies in 2 dimensions

- No previous therapy with either paclitaxel or vinorelbine, or any chemotherapy for the
past five years

- Patients who have had a previous resection for their lung cancer and present with
recurrent disease will be eligible

- Patients with other prior malignancies will be included, provided they have been
disease-free for at least five years

- Patients with adequately treated basal cell or squamous cell carcinoma of the skin,
adequately treated carcinoma in-situ of the cervix and hormone sensitive prostate
cancer will be eligible

- Karnofsky score >= 70 (Eastern Cooperative Oncology Group [ECOG] 0-2)

- White blood cell (WBC) count >= 3,500/mm^3, OR

- Absolute neutrophil count (ANC) >= 1,500/ul

- Platelet count >= 100,000/mm^3

- Serum creatinine less than 1.5 times the upper limits of normal

- Serum aspartate aminotransferase (AST) and alanine aminotransferase (ALT) less than
1.5 times the upper limits of normal

- Serum alkaline phosphatase less than 2.5 times the upper limits of normal

- No active serious infections or other condition precluding chemotherapy

- Non-pregnant and non-nursing

- Men and women of reproductive potential may not participate unless they have agreed to
use an effective contraceptive method while on the study

- Able to give informed consent

- Able to return for treatment and follow-up as specified in the protocol

Exclusion Criteria:

- Known hypersensitivity to any component of vinorelbine or paclitaxel or other required
drugs in the study

- Any comorbidity or condition which, in the opinion of the investigator, may interfere
with the assessments and procedures of this protocol

- Inability to fulfill the requirements of the protocol
We found this trial at
5
sites
?
mi
from
Omaha, NE
Click here to add this to my saved trials
Grand Island, Nebraska 68803
?
mi
from
Grand Island, NE
Click here to add this to my saved trials
North Platte, Nebraska 69101
?
mi
from
North Platte, NE
Click here to add this to my saved trials
Emile St
Omaha, Nebraska 68198
(402) 559-4000
Univ of Nebraska Med Ctr A vital enterprise in the nation’s heartland, the University of...
?
mi
from
Omaha, NE
Click here to add this to my saved trials
?
mi
from
Sioux Falls, SD
Click here to add this to my saved trials